Disposable Autoinjectors Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 180

To learn more about this report, request a free sample copy

Disposable Autoinjectors Market Overview

The report is titled as ‘Disposable Autoinjectors Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Disposable Autoinjectors market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Disposable Autoinjectors market is expected to grow at a significant rate in the near future.

The global disposable autoinjectors market in 2020 is estimated for more than US$ 45.7 Bn and expected to reach at a value of US$ 172.3 Bn by 2028 with a significant CAGR of 18.1%.

Disposable Autoinjectors Introduction

In spite of numerous challenges, there has been significant progress in the healthcare industry with the considerable transformation of the services provided by the industry, which is expected to continue in the forecast period as well.

The disposable autoinjectors are also one of the advanced medical devices that are designed to infuse a dose of a particular medication to the patient. The autoinjectors are basically of two types that are reusable and disposable.

An autoinjector is a tiny, pen-shaped medical device that comprises an intravenous needle used for impregnating a specific dose of medication to patients, by injecting the syringe needle at the targeted spot of injection, and on a push of a button.

The disposable auto-injectors are preferred more over conventional injections and syringes as these are more convenient and easy-to-use medical devices for patients. Attributable to such factors, the global disposable autoinjectors market is projected to witness impressive growth in the given timeframe.

Disposable Autoinjectors Market Dynamics

The capability to self-inject has been the core driver for the evolution of the autoinjectors across the world and presently, made them such a crucial element of the world of drug delivery medical devices for more than 25 years.

The disposable autoinjectors, generally, allows patients to use and infuse medications in emergency situations in an extremely easy and intuitive manner, which accelerates the demand of the medical device in the healthcare industry in a rapid manner.

Owing to which, the global disposable autoinjector market is projected to grow swiftly in the forthcoming years. In addition to that, the constantly rising prevalence of certain chronic diseases or certain allergies such as rheumatoid arthritis, diabetes, and multiple sclerosis are further positively fueling the demand of disposable autoinjectors across the world over the conventional injections with vials and syringes.

Owing to which, the global disposable autoinjectors market is expected to elevate briskly over the forecast period. Along with that, the disposable autoinjectors provides certain benefits to the patients such as ability to self-inject medications, easy-to-use, infusion of accurate dosage of medication, and even reduces the phobia of painful injections by providing a painless experience are few factors which further propels the demand of disposable autoinjectors among the population, hence propelling the growth of the global disposable autoinjectors market in the coming years.  

Moreover, medical devices such as disposable autoinjectors allow patients to administer their own medication, which further gains traction for the medical device as it achieves the patient’s compliance across the world. Such factors also positively drive the growth of the global disposable autoinjectors market.

Apart from that, the constant technological advancements in the healthcare industry and its medical equipment as well as strong support from the government along with favorable reimbursements is also playing a major role in boosting the growth of the global disposable autoinjectors market in the near future.

Furthermore, the ever-increasing number of aging population and poor lifestyle of the population in the modern-day world is also contributing to the growing number of diseases among the population, thereby further stimulating the demand for disposable autoinjectors worldwide.

Therefore, the global disposable autoinjectors market is estimated to observe a significant growth in the forecast timeframe. 

However, there are also a rising count of alternative options in the healthcare industry which may be estimated to confine the growth of the global disposable autoinjectors market in the near future.

Disposable Autoinjectors Market Segmentation

The global disposable autoinjectors market is initially segmented on the basis of product type into disposable auto-injectors and reusable auto-injectors. Then, the reusable auto-injectors is further segmented into prefilled auto-injectors and empty auto-injectors. Further, the market is bifurcated on the basis of disease indication into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. Then, the market is further segmented on the basis of end-use into home care settings, hospitals & clinics, and ambulatory surgical centers. And at last, the global disposable autoinjectors market is divided on the basis of region into North America, Latin America, Middle East, Asia-Pacific, Africa and Europe.

Disposable Autoinjectors Market Key Players

The key participating players of global disposable autoinjectors market are Becton, Dickinson and Company, Ypsomed AG, SHL Medical AG, E3D Elcam Drug Delivery Devices, Haselmeier, Antares Pharma, Owen Mumford Ltd., AstraZeneca, among other prominent players.

MMC Overview on Disposable Autoinjectors Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Disposable Autoinjectors market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Disposable Autoinjectors

Advantages of Disposable Autoinjectors

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Disposable Autoinjectors Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Disposable Autoinjectors Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Disposable Autoinjectors Market Snapshot

2.4.    Global Disposable Autoinjectors Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Disposable Autoinjectors Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Disposable Autoinjectors Market, By Product Type

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product Type

3.1.2.    BPS Analysis, By Product Type

3.2.    Market Revenue (US$Mn) Forecast, By Product Type

3.2.1.    Disposable Auto-Injectors 

3.2.2.    Reusable Auto-Injectors

3.2.2.1.    Prefilled Auto-Injectors 

3.2.2.2.    Empty Auto-Injectors

3.3.    Global Disposable Autoinjectors Market Attractiveness Index, By Product Type

4.    Global Disposable Autoinjectors Market, By Disease Indication

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Disease Indication

4.1.2.    BPS Analysis, By Disease Indication

4.2.    Market Revenue (US$Mn) Forecast, By Disease Indication

4.2.1.    Rheumatoid Arthritis

4.2.2.    Multiple Sclerosis

4.2.3.    Diabetes

4.2.4.    Anaphylaxis

4.2.5.    Other Therapies

4.3.    Global Disposable Autoinjectors Market Attractiveness Index, By Disease Indication

5.    Global Disposable Autoinjectors Market, By End-Use

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By End-Use

5.1.2.    BPS Analysis, By End-Use

5.2.    Market Revenue (US$Mn) Forecast, By End-Use

5.2.1.    Home Care Settings

5.2.2.    Hospitals & Clinics

5.2.3.    Ambulatory Surgical Centres

5.3.    Global Disposable Autoinjectors Market Attractiveness Index, By End-Use

6.    Global Disposable Autoinjectors Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East 

6.2.6.    Africa

6.3.    Global Disposable Autoinjectors Market Attractiveness Index, By Region

7.    North America Disposable Autoinjectors Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) Forecast, By Country

7.2.1.    U.S. Disposable Autoinjectors Market

7.2.2.    Canada Disposable Autoinjectors Market

7.3.    North America Disposable Autoinjectors Market, By Product Type

7.3.1.    Disposable Auto-Injectors 

7.3.2.    Reusable Auto-Injectors

7.3.2.1.    Prefilled Auto-Injectors 

7.3.2.2.    Empty Auto-Injectors

7.4.    North America Disposable Autoinjectors Market, By Disease Indication

7.4.1.    Rheumatoid Arthritis

7.4.2.    Multiple Sclerosis

7.4.3.    Diabetes

7.4.4.    Anaphylaxis

7.4.5.    Other Therapies

7.5.    North America Disposable Autoinjectors Market, By End-Use

7.5.1.    Home Care Settings

7.5.2.    Hospitals & Clinics

7.5.3.    Ambulatory Surgical Centres

7.6.    North America Disposable Autoinjectors Market Attractiveness Index

7.6.1.    By Country

7.6.2.    By Product Type

7.6.3.    By Disease Indication

7.6.4.    By End-Use

8.    Latin America Disposable Autoinjectors Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) Forecast, By Country

8.2.1.    Brazil Disposable Autoinjectors Market

8.2.2.    Mexico Disposable Autoinjectors Market

8.2.3.    Argentina Disposable Autoinjectors Market

8.2.4.    Rest of Latin America Disposable Autoinjectors Market

8.3.    Latin America Disposable Autoinjectors Market, By Product Type

8.3.1.    Disposable Auto-Injectors 

8.3.2.    Reusable Auto-Injectors

8.3.2.1.    Prefilled Auto-Injectors 

8.3.2.2.    Empty Auto-Injectors

8.4.    Latin America Disposable Autoinjectors Market, By Disease Indication

8.4.1.    Rheumatoid Arthritis

8.4.2.    Multiple Sclerosis

8.4.3.    Diabetes

8.4.4.    Anaphylaxis

8.4.5.    Other Therapies

8.5.    Latin America Disposable Autoinjectors Market, By End-Use

8.5.1.    Home Care Settings

8.5.2.    Hospitals & Clinics

8.5.3.    Ambulatory Surgical Centres

8.6.    Latin America Disposable Autoinjectors Market Attractiveness Index

8.6.1.    By Country

8.6.2.    By Product Type

8.6.3.    By Disease Indication

8.6.4.    By End-Use

9.    Europe Disposable Autoinjectors Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market Revenue (US$Mn) Forecast, By Country

9.2.1.    U.K. Disposable Autoinjectors Market

9.2.2.    Germany Disposable Autoinjectors Market

9.2.3.    Italy Disposable Autoinjectors Market

9.2.4.    France Disposable Autoinjectors Market

9.2.5.    Spain Disposable Autoinjectors Market

9.2.6.    Russia Disposable Autoinjectors Market

9.2.7.    Poland Disposable Autoinjectors Market

9.2.8.    BENELUX Disposable Autoinjectors Market

9.2.9.    NORDIC Disposable Autoinjectors Market

9.2.10.    Rest of Europe Disposable Autoinjectors Market

9.3.    Europe Disposable Autoinjectors Market, By Product Type

9.3.1.    Disposable Auto-Injectors 

9.3.2.    Reusable Auto-Injectors

9.3.2.1.    Prefilled Auto-Injectors 

9.3.2.2.    Empty Auto-Injectors

9.4.    Europe Disposable Autoinjectors Market, By Disease Indication

9.4.1.    Rheumatoid Arthritis

9.4.2.    Multiple Sclerosis

9.4.3.    Diabetes

9.4.4.    Anaphylaxis

9.4.5.    Other Therapies

9.5.    Europe Disposable Autoinjectors Market, By End-Use

9.5.1.    Home Care Settings

9.5.2.    Hospitals & Clinics

9.5.3.    Ambulatory Surgical Centres

9.6.    Europe Disposable Autoinjectors Market Attractiveness Index

9.6.1.    By Country

9.6.2.    By Product Type

9.6.3.    By Disease Indication

9.6.4.    By End-Use

10.    Asia Pacific Disposable Autoinjectors Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market Revenue (US$Mn) Forecast, By Country

10.2.1.    China Disposable Autoinjectors Market

10.2.2.    India Disposable Autoinjectors Market

10.2.3.    Japan Disposable Autoinjectors Market

10.2.4.    Australia And New Zealand Disposable Autoinjectors Market

10.2.5.    South Korea Disposable Autoinjectors Market

10.2.6.    ASEAN Disposable Autoinjectors Market

10.2.7.    Rest of Asia Pacific Disposable Autoinjectors Market

10.3.    Asia Pacific Disposable Autoinjectors Market, By Product Type

10.3.1.    Disposable Auto-Injectors 

10.3.2.    Reusable Auto-Injectors

10.3.2.1.    Prefilled Auto-Injectors 

10.3.2.2.    Empty Auto-Injectors

10.4.    Asia Pacific Disposable Autoinjectors Market, By Disease Indication

10.4.1.    Rheumatoid Arthritis

10.4.2.    Multiple Sclerosis

10.4.3.    Diabetes

10.4.4.    Anaphylaxis

10.4.5.    Other Therapies

10.5.    Asia Pacific Disposable Autoinjectors Market, By End-Use

10.5.1.    Home Care Settings

10.5.2.    Hospitals & Clinics

10.5.3.    Ambulatory Surgical Centres

10.6.    Asia Pacific Disposable Autoinjectors Market Attractiveness Index

10.6.1.    By Country

10.6.2.    By Product Type

10.6.3.    By Disease Indication

10.6.4.    By End-Use

11.    Middle East Disposable Autoinjectors Market, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market Revenue (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Disposable Autoinjectors Market

11.2.2.    Israel Disposable Autoinjectors Market

11.2.3.    Oman Disposable Autoinjectors Market

11.2.4.    Rest of Middle East Disposable Autoinjectors Market

11.3.    Middle East Disposable Autoinjectors Market, By Product Type

11.3.1.    Disposable Auto-Injectors 

11.3.2.    Reusable Auto-Injectors

11.3.2.1.    Prefilled Auto-Injectors 

11.3.2.2.    Empty Auto-Injectors

11.4.    Middle East Disposable Autoinjectors Market, By Disease Indication

11.4.1.    Rheumatoid Arthritis

11.4.2.    Multiple Sclerosis

11.4.3.    Diabetes

11.4.4.    Anaphylaxis

11.4.5.    Other Therapies

11.5.    Middle East Disposable Autoinjectors Market, By End-Use

11.5.1.    Home Care Settings

11.5.2.    Hospitals & Clinics

11.5.3.    Ambulatory Surgical Centres

11.6.    Middle East Disposable Autoinjectors Market Attractiveness Index

11.6.1.    By Country

11.6.2.    By Product Type

11.6.3.    By Disease Indication

11.6.4.    By End-Use

12.    Africa Disposable Autoinjectors Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market Revenue (US$Mn) Forecast, By Country

12.2.1.    South Africa Disposable Autoinjectors Market

12.2.2.    Egypt Disposable Autoinjectors Market

12.2.3.    North Africa Disposable Autoinjectors Market

12.2.4.    Rest of Africa Disposable Autoinjectors Market

12.3.    Africa Disposable Autoinjectors Market, By Product Type

12.3.1.    Disposable Auto-Injectors 

12.3.2.    Reusable Auto-Injectors

12.3.2.1.    Prefilled Auto-Injectors 

12.3.2.2.    Empty Auto-Injectors

12.4.    Africa Disposable Autoinjectors Market, By Disease Indication

12.4.1.    Rheumatoid Arthritis

12.4.2.    Multiple Sclerosis

12.4.3.    Diabetes

12.4.4.    Anaphylaxis

12.4.5.    Other Therapies

12.5.    Africa Disposable Autoinjectors Market, By End-Use

12.5.1.    Home Care Settings

12.5.2.    Hospitals & Clinics

12.5.3.    Ambulatory Surgical Centres

12.6.    Africa Disposable Autoinjectors Market Attractiveness Index

12.6.1.    By Country

12.6.2.    By Product Type

12.6.3.    By Disease Indication

12.6.4.    By End-Use

13.    Recommendation

13.1.    Market Strategy

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    List and Company Overview of Global Key Players

14.3.    Company Profiles

14.3.1.    Becton, Dickinson and Company

14.3.1.1.    Company Overview

14.3.1.2.    Financial Overview

14.3.1.3.    Product Portfolio

14.3.1.4.    Key Developments

14.3.1.5.    Business Strategies

14.3.2.    Ypsomed AG

14.3.3.    SHL Medical AG

14.3.4.    E3D Elcam Drug Delivery Devices

14.3.5.    Haselmeier

14.3.6.    Antares Pharma

14.3.7.    Owen Mumford Ltd.

14.3.8.    AstraZeneca

15.    Acronyms

Select License Type

Frequently Asked Questions

The global disposable autoinjectors market in 2020 is estimated for more than US$ 45.7 Bn and expected to reach at a value of US$ 172.3 Bn by 2028 with a significant CAGR of 18.1%.

The capability to self-inject has been the core driver for the evolution of the autoinjectors and constantly rising prevalence of certain chronic diseases or certain allergies such as rheumatoid arthritis, diabetes, and multiple sclerosis are the key factors driving the growth of market

The global disposable autoinjectors market is initially segmented on the basis of product type, disease indication, end-use, and region

The key participating players of global disposable autoinjectors market are Becton, Dickinson and Company, Ypsomed AG, SHL Medical AG, E3D Elcam Drug Delivery Devices, Haselmeier, Antares Pharma, Owen Mumford Ltd., AstraZeneca, among other prominent players.



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK